Merits and complexities of modeling multiple sclerosis in non-human primates: implications for drug discovery

Bert A 't Hart1,2, Jon D Laman2, Yolanda S Kap1

  • 1a Department of Immunobiology , Biomedical Primate Research Centre , Rijswijk , The Netherlands.

Abstract

Insights

Developing a more predictive multiple sclerosis (MS) model using adult non-human primates is crucial. This study explores an experimental autoimmune encephalomyelitis (EAE) model in marmosets, showing MS-like pathology and potential therapeutic targets.

Area of Science:

  • Neuroimmunology
  • Translational Medicine
  • Primate Models

Background:

  • Current preclinical models for multiple sclerosis (MS) inadequately predict clinical success.
  • Experimental autoimmune encephalomyelitis (EAE) in adolescent mice lacks human immune system complexity.
  • A translational gap exists between animal models and human patient outcomes.

Purpose of the Study:

  • To evaluate an experimental autoimmune encephalomyelitis (EAE) model in adult non-human primates.
  • To determine if a conventionally-housed marmoset model can bridge the translational gap for MS research.
  • To investigate a novel EAE model with pathological similarities to MS.

Main Methods:

  • Utilizing adult common marmosets (Callithrix jacchus) in a conventionally-housed colony.
  • Inducing experimental autoimmune encephalomyelitis (EAE) in marmosets.
  • Analyzing the pathological similarities between the marmoset EAE model and human MS.

Main Results:

  • The marmoset EAE model exhibits remarkable pathological similarity to human MS.
  • MS-like pathology arises from interactions between effector memory T cells and γ1-herpesvirus (CalHV3)-infected B cells.
  • A small subset of CalHV3-infected B cells (<0.05%) is implicated in chronic inflammatory demyelination.

Conclusions:

  • An EAE model in adult, pathogen-educated marmosets offers enhanced translational relevance for MS.
  • Targeting CalHV3-infected B cells may be a viable strategy to limit MS-like pathology.
  • This primate model could improve the prediction of therapeutic efficacy for MS treatments.

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.9K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
167
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
291
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
273
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
38.2K
Protein Complex Assembly02:41

Protein Complex Assembly

Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
16.9K